The Lung Cancer Channel is supported with funding from Johnson & Johnson (Gold) and Takeda (Gold).

VJOncology is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.

ESMO 2018 | Challenges and treatment of CNS metastases in NSCLC

Name: Challenges and treatment of CNS metastases in NSCLC
Uploaded: 2018-10-19T00:00:00.000Z
Duration: 58 s
Description: Sanjay Popat, PhD, MBBS, FRCP, of the Royal Marsden NHS Foundation Trust, London, UK, discusses the challenges and treatment of CNS metastases in non-small cell lung cancer from the European Society for Medical Oncology (ESMO) 2018 Congress, in Munich, Germany.

Sanjay Popat • 19 Oct 2018

ESMO 2018

Lung Cancer Non-Small Cell Lung Cancer Alectinib Brigatinib Crizotinib

ALTA-1L

Sanjay Popat, PhD, MBBS, FRCP, of the Royal Marsden NHS Foundation Trust, London, UK, discusses the challenges and treatment of CNS metastases in non-small cell lung cancer from the European Society for Medical Oncology (ESMO) 2018 Congress, in Munich, Germany.